Half Year 2021 Regis Healthcare Ltd Earnings Call Transcript

The following is excerpted from the question-and-answer section of the transcript.

Question: Thomas Godfrey - UBS Investment Bank, Research Division - Analyst : I just wanted to start with occupancy, and it's obviously encouraging to see over sort of the last couple of months, the group rates improve. I'm just wondering if you could give us a bit more color around what you're seeing from your key referral sort of pathways and what's happening on the ground to see that sort of bounce back? And how much is sort of the Victorian market normalizing?

Question: Thomas Godfrey - UBS Investment Bank, Research Division - Analyst : Got it. Secondly, I just wanted to ask around the Netherlands sanction. I just sort of wanted to get a bit more detail around the operational and financial impacts that's happening at that site. Maybe if you could give us an idea of what occupancy is sitting at? And did you still have some RADs that you're looking to collect on that site being a recently opened greenfield?

Question: Thomas Godfrey - UBS Investment Bank, Research Division - Analyst : Got it. And maybe just last one for me. I've got to throw in a Royal Commission question. But I just wanted to touch on one of the responses I saw you guys submit just around RADs and how the government is thinking about that piece of the regulatory framework moving forward. Obviously, your positioning is very much in favor of it continuing to be sort of a centerpiece of the landscape. But is there a situation -- in terms of what you're hearing out of the Royal Commission out of government, is there a situation where they could realistically sort of repeal the RAD framework? And how would that sort of play out in terms of recapitalizations across the sector? REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies. FEBRUARY 24, 2021 / NTS, REG.AX - Half Year 2021 Regis Healthcare Ltd Earnings Call

Question: Thomas Godfrey - UBS Investment Bank, Research Division - Analyst : Got it. We'll wait for Friday.